Stockreport

BioNTech to acquire Neon to strengthen global leadership position in T cell therapies

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Further expands BioNTech’s growing CAR-T and TCR therapy pipeline through addition of neoantigen specific cell therapies, including a T cell therapy targeting shared RAS [Read more]